Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
A Phase I and Randomized Phase II Trial of Radium-223 Dichloride, M3814, Avelumab in Advanced Metastatic Castrate-Resistant Prostate Cancer mCRPC
Sleep Hygiene Education, ReadiWatchTM Actigraphy, And Telehealth Cognitive Behavioral Training For Insomnia Effect, On Symptom Relief For Men With Prostate Cancer Receiving Androgen Deprivation Therapy ADT SHERE-Relief 2.
Study Type: Supportive Care
Phase: Feasibility/Pilot
NCTID: NCT05582759
Principal Investigator:
Jamie Myers
A Phase III Randomized, Placebo-controlled, Double-blind Study of Niraparib in Combination with Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Subjects with Metastatic Prostate Cancer
Study Type: Treatment
Phase: III
NCTID: NCT03748641
Principal Investigator:
Elizabeth Wulff-Burchfield
A Phase 2 Open-label Extension Study for Subjects with Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study ICON study number: 0798/0661
A Phase I Open-Label, Multi-Center Study of PSMA Targeted Genetically Modified Chimeric Antigen Receptor T Cells in Patients with Metastatic Castration Resistant Prostate Cancer
A Phase II Multiple-Dose, Multiple-Arm, Parallel Assignment Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of XmAb20717 Alone or in Combination with Chemotherapy or Targeted Therapies in Selected Subjects with Metastatic Castration-Resistant Prostate Cancer
HoLEP prior to Radiation Therapy for Patients with LUTS/Retention and Concurrent Prostate Cancer
Study Type: Supportive Care
Phase: N/A
NCTID: NCT03802851
Principal Investigator:
Donald Neff